SEC-sourced researchBeta
CBIH
Cannabis Bioscience International Holdings, Inc.
Company comparison ↗
Data passport
- CIK
- 0001411057
- Exchange
- OTC
- Business activity
- Services-Commercial Physical & Biological Research · SIC 8731
- Financial inputs
- 6/6
- Filing date
- Oct 16, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| May 2024 | 248,841.0000 | Sep 22, 2025 |
| May 2025 | 303,022.0000 | Sep 22, 2025 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| May 2025 | 303,022.0000 | -548,820.0000 | -329,627.0000 | 31,880.0000 | 1,195,463.0000 | Sep 22, 2025 |
| May 2024 | 248,841.0000 | -651,345.0000 | -479,382.0000 | 57,162.0000 | 1,136,175.0000 | Sep 22, 2025 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
34/100
Profitability0
Growth72
Balance sheet0
Cash generation0
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $303.02K | Jun 1, 2024 – May 31, 2025 | Sep 22, 2025 | 10-K |
| Previous period revenueRevenues | $248.84K | Jun 1, 2023 – May 31, 2024 | Sep 22, 2025 | 10-K |
| Net incomeNetIncomeLoss | -$548.82K | Jun 1, 2024 – May 31, 2025 | Sep 22, 2025 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$329.63K | Jun 1, 2024 – May 31, 2025 | Sep 22, 2025 | 10-K |
| Total assetsAssets | $31.88K | May 31, 2025 | Sep 22, 2025 | 10-K |
| Total liabilitiesLiabilities | $1.2M | May 31, 2025 | Sep 22, 2025 | 10-K |